Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet — PCD Pharma Franchise, Manufacturers & Suppliers in India



Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet — available for PCD franchise from Trumac Healthcare

Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet

Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg
Form: Tablet
Class: Non-Nucleoside Reverse Transcriptase Inhibitor — Antiretroviral
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

<strong>Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet</strong> is available from <strong>Trumac Healthcare</strong>, a WHO-GMP certified pharmaceutical manufacturer and supplier in India. This tablet formulation is offered on <strong>monopoly PCD pharma franchise</strong>, <strong>wholesale and distributor supply</strong>, and <strong>third party / contract manufacturing</strong> basis across all Indian states. We already manufacture Tenofovir Disoproxil Fumarate across our existing range, so supply is established and lead times are short.

Therapeutic Indications
  • HIV-1 infection in adults and adolescents, as part of combination ART
  • NACO first-line regimens prior to dolutegravir-based protocols
  • Used with NRTI backbone such as tenofovir+lamivudine
Mechanism of Action

Binds directly to a hydrophobic pocket on HIV-1 reverse transcriptase and inhibits enzyme activity by non-competitive allosteric mechanism, blocking viral DNA synthesis.

Dosage & Administration
  • Dosage of Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Rash (sometimes severe — Stevens-Johnson syndrome)
  • CNS effects: dizziness, vivid dreams, insomnia
  • Hepatotoxicity
  • Hyperlipidaemia
Contraindications
  • Hypersensitivity to the drug or any excipient
  • Severe hepatic impairment
  • Never use as monotherapy — always combine with at least 2 other active antiretrovirals
  • Pregnancy/lactation only under specialist supervision
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

PCD Pharma Franchise & Third Party Manufacturing — Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet

  • ✓ WHO-GMP certified manufacturing — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: <strong>Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg</strong>. Trumac Healthcare supplies this nnrti antiretroviral with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet in India?

Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

Is Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet available for PCD pharma franchise on monopoly basis?

Yes. Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate?

Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate is classified as a NNRTI Antiretroviral — Non-Nucleoside Reverse Transcriptase Inhibitor — Antiretroviral.

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Emtricitabine 200 mg Tenofovir Disoproxil Fumarate 300 mg Efavirenz 600 mg Tablet?

Get Pricing & Franchise Terms →